Clinical Trials Browser

Phase 3 × Malignant Carcinoid Syndrome × Octreotide × Clear all

NCT00412061 2014-11-21

RADIANT-2

Phase 3 Completed

429 enrolled 13 charts

Carcinoid Tumor, Carcinoma, Malignant Carcinoid Syndrome, Neoplasms